B7-H3:在前列腺癌中作为免疫治疗的强大目标
Rafael Pulido1, José I López2, Caroline E Nunes-Xavier3
1Biobizkaia Health Research Institute, Barakaldo, Spain; Ikerbasque, Basque Foundation for Science, Bilbao, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos III, Madrid, Spain.
Trends in cancer
|June 5, 2024
概括
向促进瘤生长的蛋白质B7-H3,对晚期前列腺癌 (PCa) 免疫疗法显示出希望. 本综述探讨了最近关于B7-H3作为PCa治疗中的治疗点的发现.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- B7-H3是一种免疫检查点糖蛋白.
- 它促进瘤的免疫逃避和生长.
- B7-H3在前列腺癌细胞上表达高.
研究的目的:
- 总结和讨论最近关于在前列腺癌 (PCa) 治疗中准B7-H3的发现.
- 评估B7-H3作为高级PCa的治疗点的适用性.
主要方法:
- 在PCa中对B7-H3的最新研究的文献综述.
- 在前列腺癌中分析B7-H3表达模式.
- 讨论针对B7-H3.3.的潜在免疫治疗策略.
主要成果:
- B7-H3表达是PCa的一个重要生物标志物.
- 向B7-H3为PCa免疫疗法提供了一个可行的策略.
- 最近的发现支持B7-H3作为高级PCa治疗的强大候选人.
结论:
- B7-H3是针对晚期前列腺癌的新型免疫疗法的一个有希望的目标.
- 对B7-H3向疗法的进一步研究可能会为PCa患者改善治疗结果.
相关概念视频
01:27Tumor Immunotherapy
514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K